Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. (Q54725289)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Neale GA

1

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

Coustan-Smith E

2

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

Stow P

3

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

Pan Q

4

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

Chen X

5

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

Pui CH

6

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

Campana D

7

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

18

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

5

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

934-938

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

21 January 2018

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

21 January 2018

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

21 January 2018

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

21 January 2018

New definition of remission in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

21 January 2018

'Ponte di Legno' Working Group--report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April - 1 May 2002.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

21 January 2018

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

21 January 2018

Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

21 January 2018

Determination of minimal residual disease in leukaemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

21 January 2018

Minimal residual disease in leukaemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

21 January 2018

Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

21 January 2018

Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

21 January 2018

Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

21 January 2018

Detection of minimal residual disease in acute leukemia by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

21 January 2018

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal r

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403348

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403348

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15029212

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54725289&oldid=2212571891"